510(k) device
xTAG Cystic Fibrosis 39 Kit v2
Luminex Molecular Diagnostics, Inc. · System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection (NUA, Class II) · First FDA decision Sep 1, 2009, newest Dec 15, 2016Genetic and newborn screening
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
1
Naming "xTAG"
MAUDE reports
1
Brand "xTAG", since 2015
PubMed studies
216
Mentioning "xTAG"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing xTAG Cystic Fibrosis 39 Kit v2
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K163347 · Decided Dec 15, 2016 · 17 days after receipt
Device type: System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection (NUA) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "xTAG", any status and sponsor, newest update first.
Luminex Molecular DiagnosticsNot on our public-company list
NCT01787227 · 1,500 participants · Start Jan 2015 · Primary completion Sep 2015
Device: xTAG RPP · For: Respiratory Tract Infection; Bronchitis; Bronchiolitis and 1 more
Sites: St Louis, Missouri; Lake Success, New York; Temple, Texas · 4 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "xTAG", and for the whole product code for context.
This brand
1 reports: 1 malfunction, 0 injury, 0 death
Whole product code NUA
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
- XTAG RESPIRATORY VIRAL PANELMalfunction
MW5066367 · Received Nov 23, 2016 · Event dated Jul 12, 2016
Device type: Respiratory Virus Panel Nucleic Acid Assay System (OCC)
Device problem as coded: Under-Sensing; Output below Specifications
Patient problem as coded: No Known Impact Or Consequence To Patient
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "xTAG"[tiab]. The summary above synthesizes these.
- Serotype determination of Salmonella by xTAG assay.
Zheng Z, Zheng W, Wang H, et al. · J Microbiol Methods · 2017Research Support, Non-U.S. Gov't
- The application research of xTAG GPP multiplex PCR in the diagnosis of persistent and chronic diarrhea in children.
Wang C, Zhou X, Zhu M, et al. · BMC Pediatr · 2020Research Support, Non-U.S. Gov't
- Development of an xTAG-multiplex PCR array for the detection of four avian respiratory viruses.
Cong F, Zhu Y, Liu X, et al. · Mol Cell Probes · 2018Evaluation Study, Research Support, Non-U.S. Gov't
- A multiplex xTAG assay for the simultaneous detection of five chicken immunosuppressive viruses.
Cong F, Zhu Y, Wang J, et al. · BMC Vet Res · 2018
- Comparative Evaluation of Luminex xTAG® Gastrointestinal Pathogen Panel and Direct-From-Stool Real-Time PCR for Detection of C. difficile Toxin tcdB in Stool Samples from a Pediatric Population.
Tyrrell H, Morin SBN, Lloyd CD, et al. · Microorganisms · 2022
- xTAG RVP assay: analytical and clinical performance.
Krunic N, Yager TD, Himsworth D, et al. · J Clin Virol · 2007Review
- Principles of the xTAG respiratory viral panel assay (RVP Assay).
Merante F, Yaghoubian S, Janeczko R · J Clin Virol · 2007Review
- Multiplex Detection of SNPs for Genetic Monitoring in Laboratory Mice by Luminex xTAG Assay.
Zhou J, Wei J, Wang H, et al. · Genes (Basel) · 2024Research Support, Non-U.S. Gov't
- Comparison of Luminex xTAG® RVP fast assay and real time RT-PCR for the detection of respiratory viruses in adults with community-acquired pneumonia.
Luchsinger V, Prades Y, Ruiz M, et al. · J Med Virol · 2016Comparative Study, Research Support, Non-U.S. Gov't
- Development of a Luminex xTAG Assay for the Rapid Detection of Five Aminoglycoside Resistance Genes Both in Staphylococci and Enterococci.
Xu F, Chen J, Xiao C, et al. · Microb Drug Resist · 2019
- QIAstat-Dx gastrointestinal panel and Luminex xTAG gastrointestinal pathogen panel comparative evaluation.
Giffen SR, Sadler JM, Miller MB · J Clin Microbiol · 2023
- Evaluation of the xTAG Gastrointestinal Pathogen Panel Assay for the Detection of Enteric Pathogens in Kuwait.
Albert MJ, Rotimi VO, Iqbal J, et al. · Med Princ Pract · 2016
Other devices of this type
Also filed under product code NUA.
- Tag-It Cystic Fibrosis KitTm Bioscience Corporation · De Novo 2006
- Esensor Cystic Fibrosis Carrier Detection System, Model Esensor 4800Clinical Micro Sensors, Inc. · 510(k) 2006
- Xtag CF60 Kit V2Luminex Molecular Diagnostics, Inc. · 510(k) 2009
- Verigene Cftr Nucleic Acid Test and Verigene Cftr Polyt Nucleic Acid TestNanosphere, Inc. · 510(k) 2009
- Esensor Cf Genotyping Testm Esensor SystemOsmetech Molecular Diagnostics · 510(k) 2009
- Inplex Cf Molecular TestThird Wave Technologies, Inc. · 510(k) 2008
- Cystic Fibrosis Genotyping Assay, Model 6L20-01Celera Diagnostics · 510(k) 2007
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.